Compare DEI & BHVN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | DEI | BHVN |
|---|---|---|
| Founded | 1971 | 2013 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Real Estate Investment Trusts | Biotechnology: Pharmaceutical Preparations |
| Sector | Real Estate | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.9B | 2.1B |
| IPO Year | 2006 | 2022 |
| Metric | DEI | BHVN |
|---|---|---|
| Price | $9.98 | $15.34 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 12 | 17 |
| Target Price | $12.40 | ★ $23.73 |
| AVG Volume (30 Days) | 1.9M | ★ 2.9M |
| Earning Date | 11-03-2026 | 10-29-2026 |
| Dividend Yield | ★ 7.50% | N/A |
| EPS Growth | N/A | ★ 26.08 |
| EPS | ★ N/A | N/A |
| Revenue | ★ $1,003,982,000.00 | N/A |
| Revenue This Year | $1.79 | N/A |
| Revenue Next Year | $2.61 | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 1.77 | N/A |
| 52 Week Low | $9.04 | $7.48 |
| 52 Week High | $12.97 | $18.24 |
| Indicator | DEI | BHVN |
|---|---|---|
| Relative Strength Index (RSI) | 50.77 | 63.07 |
| Support Level | $9.24 | $13.56 |
| Resistance Level | $10.10 | $16.85 |
| Average True Range (ATR) | 0.26 | 1.00 |
| MACD | 0.08 | 0.40 |
| Stochastic Oscillator | 73.56 | 88.87 |
Douglas Emmett Inc is an integrated, self-administered, and self-managed REIT. The group focuses on owning, acquiring, developing, and managing a substantial market share of office properties and multifamily communities in neighborhoods with supply constraints, high-end executive housing, and key lifestyle amenities. Its properties are located in the Beverly Hills, Brentwood, Burbank, Century City, Olympic Corridor, Santa Monica, Sherman Oaks/Encino, Warner Center/Woodland Hills and Westwood submarkets of Los Angeles County, California, and in Honolulu, Hawaii. It has two business segments: the office segment and multifamily segment, of which Office segment derives maximum revenue.
Biohaven Ltd is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of life-changing treatments in key therapeutic areas, including immunology, neuroscience, and oncology. Its product pipeline includes Glutamate, Myostatin, Ion channels, Inflammation & Immunology, and Oncology. The company's products target diseases such as neuromuscular and metabolic diseases, antibody-drug conjugates for cancer, obsessive-compulsive disorder and others. Its pipeline products include: BHV-2000, BHV-7000, BHV-2100, BHV-8000, BHV-1310, BHV-1300, BHV-1400, BHV-1600, BHV-1530, and BHV-1500.